ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 266763 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 266763; 2) Community: the network communities that were significantly associated with the response to NSC 266763; 3) Molecule: the relationships between components within communities and NSC 266763; 4) MDR: the compounds that were significantly associated with the NSC 266763.

NSC Compound Enrichment Correlation
NSC 643846 Null 0.0285477013888569 0.2647802
NSC 670805 Null 0.0285477013888569 0.048986339
NSC 683556 Camptothecin Derivative 0.0285477013888569 0.043684727
NSC 700363 Liposomal Annamycin 0.0285477013888569 0.12268137
NSC 720374 1-(4-nitrophenyl)-3-methyl-6,7-methylenedioxy-isoquinoline 0.0285477013888569 0.24950345
NSC 726365 Null 0.0285477013888569 0.2739644
NSC 730690 Null 0.0303734648501639 -0.19075295
NSC 733252 Null 0.0303734648501639 -0.17785063
NSC 762148 N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)-N'-(3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanth 0.0303734648501639 -0.14803868
NSC 763278 (E)-8-(3,4,5-trimethoxybenzylidene)-4-(3,4,5-trimethoxyphenyl)-3,4,5,6,7,8-hexahydroquinazolin-2-amine 0.0303734648501639 -0.031155781
Total:19  Current:10    [First] [Prev] [Next] [Last]